Anemia in Myelodysplastic Syndromes

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-17
Clinical Trial Update: A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia [Phase 2]
A Phase 2a trial update for HT-6184 in patients with IPSS-R very low/low/intermediate risk myelodysplastic syndromes and anemia, with the st…